You are searching for: Phase 2 Trial

T97719
Target Info
Target Name HUMAN bruton tyrosine kinase (BTK)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Acalabrutinib Drug Info
T94549
Target Info
Target Name HUMAN angiopoietin-2 (ANG-2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs LY3127804 Drug Info
T94912
Target Info
Target Name HUMAN C5a receptor (C5aR)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Avdoralimab Drug Info
T97747
Target Info
Target Name HUMAN C-C chemokine receptor 5 (CCR5)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Leronlimab Drug Info
T90070
Target Info
Target Name HUMAN interleukin 8 (IL8)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs BMS-986253 Drug Info
T94119
Target Info
Target Name HUMAN PI3-kinase delta (PIK3CD)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Duvelisib Drug Info
T94131
Target Info
Target Name HUMAN PI3-kinase gamma (PIK3CG)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs Duvelisib Drug Info
T89083
Target Info
Target Name HUMAN toll-like receptor 2 (TLR2)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs PUL-042 Drug Info
T89415
Target Info
Target Name HUMAN toll-like receptor 6 (TLR6)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs PUL-042 Drug Info
T87633
Target Info
Target Name HUMAN toll-like receptor 9 (TLR9)
Target type Target in Phase 2 Trial
Disease Coronavirus Disease 2019 (COVID-19)
Drugs PUL-042 Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.